Noramco™
Zhen Yang has a strong background in chemistry, with experience in various research and analytical roles. Currently, Zhen serves as the Chair of the Delaware Section of the American Chemical Society and President of YM American Academy 美东学苑, assisting Chinese students in applying to schools in the US, UK, and Canada. Prior to these roles, Zhen held positions at Noramco, Inc., Wilmington PharmaTech, Lonza, and other scientific organizations, showcasing a dedication to the field over the years. With a Ph.D. in Chemistry from Nanjing University, Zhen also completed postdoctoral work at Texas Tech University.
This person is not in the org chart
Noramco™
Noramco, headquartered in Wilmington, Delaware, is a global leader in the production of controlled substances for the pharmaceutical industry, for medicines used to treat attention deficit hyperactivity disorder, pain, addiction, and for abuse-deterrent formulations. We realize our success through a keen focus on commercial and operational excellence as well as continuing strategic growth. Our global footprint includes Athens, GA, Wilmington, DE and Neuhausen, Switzerland. Specialists in controlled substance development and manufacturing, Noramco is a partner to the pharmaceutical industry: – Focusing on high-purity controlled substances – Leveraging intellectual property to devise the most efficient routes to APIs – Providing analytical data, chemical and physical properties, stability studies and regulatory assistance – Formulation friendly particle size grades and extended technical packages – Delivering DEA-compliant security and production capacity, from kilos to multi-ton supply – Supporting world-class supply security of controlled-substances, from schedule I to schedule III